ATE383341T1 - Substituierte caprolactam carbonate und ether sowie deren verwendung als anti-tumor wirkstoffe - Google Patents

Substituierte caprolactam carbonate und ether sowie deren verwendung als anti-tumor wirkstoffe

Info

Publication number
ATE383341T1
ATE383341T1 AT01975824T AT01975824T ATE383341T1 AT E383341 T1 ATE383341 T1 AT E383341T1 AT 01975824 T AT01975824 T AT 01975824T AT 01975824 T AT01975824 T AT 01975824T AT E383341 T1 ATE383341 T1 AT E383341T1
Authority
AT
Austria
Prior art keywords
carbonate
ether
active ingredients
tumor active
compounds
Prior art date
Application number
AT01975824T
Other languages
English (en)
Inventor
Frederick Kinder
Richard Versace
Kenneth Bair
Original Assignee
Novartis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Pharma Gmbh filed Critical Novartis Pharma Gmbh
Application granted granted Critical
Publication of ATE383341T1 publication Critical patent/ATE383341T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/12—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
AT01975824T 2000-05-11 2001-05-09 Substituierte caprolactam carbonate und ether sowie deren verwendung als anti-tumor wirkstoffe ATE383341T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US56866700A 2000-05-11 2000-05-11

Publications (1)

Publication Number Publication Date
ATE383341T1 true ATE383341T1 (de) 2008-01-15

Family

ID=24272224

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01975824T ATE383341T1 (de) 2000-05-11 2001-05-09 Substituierte caprolactam carbonate und ether sowie deren verwendung als anti-tumor wirkstoffe

Country Status (11)

Country Link
EP (1) EP1282604B1 (de)
JP (1) JP2003532711A (de)
CN (1) CN1191237C (de)
AT (1) ATE383341T1 (de)
AU (1) AU2001295206A1 (de)
BR (1) BR0110641A (de)
CA (1) CA2405892C (de)
DE (1) DE60132324T2 (de)
ES (1) ES2299515T3 (de)
PT (1) PT1282604E (de)
WO (1) WO2001085697A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1856486A (zh) * 2003-07-25 2006-11-01 诺瓦提斯公司 取代的内酰胺和它们作为抗癌剂的用途
DE10349669B3 (de) * 2003-10-24 2005-05-25 Aventis Pharma Deutschland Gmbh Bengamide-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
US7153846B2 (en) 2003-10-24 2006-12-26 Sanofi-Aventis Deutschland Gmbh Bengamide derivatives, process for preparing them, and their use
FR2878525B1 (fr) 2004-11-29 2007-02-23 Aventis Pharma Sa Bengamides possedant un cycle caprolactame substitue, procede de preparation, compositions les contenant et utilisation
FR2878528B1 (fr) 2004-11-29 2008-05-16 Aventis Pharma Sa 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation
FR2901555A1 (fr) 2006-05-24 2007-11-30 Sanofi Aventis Sa 2-alcoxy-3,4,5-trihydroxy-alkylamide-benzothiazepine, leur preparation, compositions les contenant et utilisation
FR2901556A1 (fr) 2006-05-24 2007-11-30 Sanofi Aventis Sa Derives de 2-alcoxy-3,4,5-trihydroxy-alkylamide, leur preparation, compositions les contenant et utilisation
FR2901554B1 (fr) 2006-05-24 2011-04-01 Sanofi Aventis 2-alcoxy-3,4,5-trihydroxy-alkylamide-benzazepine, leur preparation, compositions les contenant et utilisation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4831135A (en) * 1986-06-18 1989-05-16 The Regents Of The University Of California Bengamide anthelmintics
GB9411841D0 (en) * 1994-06-14 1994-08-03 Pharma Mar Sa New antitumoral compounds from jaspis sponge
CO5140099A1 (es) * 1998-11-17 2002-03-22 Novartis Ag Ciertas caprolactamas sustituidas, composiciones farmaceuticas que las contienen, y su uso en el tratamiento de tumores

Also Published As

Publication number Publication date
DE60132324T2 (de) 2008-12-24
CA2405892C (en) 2009-07-07
CN1191237C (zh) 2005-03-02
CA2405892A1 (en) 2001-11-15
BR0110641A (pt) 2003-03-18
WO2001085697A1 (en) 2001-11-15
CN1429213A (zh) 2003-07-09
PT1282604E (pt) 2008-04-11
DE60132324D1 (de) 2008-02-21
AU2001295206A1 (en) 2001-11-20
JP2003532711A (ja) 2003-11-05
EP1282604B1 (de) 2008-01-09
EP1282604A1 (de) 2003-02-12
ES2299515T3 (es) 2008-06-01

Similar Documents

Publication Publication Date Title
TR200102800T2 (tr) Yeni bileşikler.
DE60112609D1 (en) Pyrazolopyridine
MXPA03004780A (es) Nuevas sulfamidas.
ATE286500T1 (de) 1,2,3,4-tetrahydroisochinolin-derivate
MY127718A (en) Dolastatin 10 derivatives.
DE60204452D1 (de) Pyrazolo[1,5]pyridinderivate
IS6658A (is) Ný efnasambönd
TR200401029T4 (tr) Asilfenil-üre türevleri, imalat yöntemleri ve ilaç maddesi olarak kullanımları
YU45403A (sh) Novi 1,2-difenil-azetidinoni, postupak za njihovu proizvodnju, lekovi koji sadrže ova jedinjenja i njihova primena za lečenje poremećaja u metabolizmu lipida
UY27368A1 (es) Nuevos compuestos
HK1048990A1 (en) Novel compounds.
DE60112330D1 (en) Pyrazolopyridinderivate
BR0209127A (pt) compostos, composições farmacêuticas, métodos para o tratamento de dores, métodos para a modulação de uma resposta farmacológica e usos de compostos
BR0209129A (pt) Compostos, composições farmacêuticas, métodos para tratamento de dores, métodos para modulação de uma resposta farmacológica e usos de compostos
BRPI0113162B8 (pt) compostos ariloxialquilaminas nao-imidazólicos e composição farmacêutica compreendendo os referidos compostos
IL115920A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING omega-SUBSTITUTED 2,2-DICHLOROALKANECARBOXYLIC ACIDS, SOME SUCH NEW COMPOUNDS AND PROCESS FOR THEIR PREPARATION
BR0109109A (pt) Composto, uso do mesmo, processo para prepará-lo, composição farmacêutica, e, método de tratar um estado doentio mediado por ccr5 em mamìferos
IL160171A0 (en) Depsipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
SE9804212D0 (sv) Compounds
RS19504A (en) Novel compounds and compositions as cathepsin inhibitors
ATE383341T1 (de) Substituierte caprolactam carbonate und ether sowie deren verwendung als anti-tumor wirkstoffe
DE60215313D1 (de) Indolderivate und deren verwendung als gnrh antagonisten
BR0318521A (pt) arilindenopiridinas e arilindenopirimidinas e métodos terapêuticos e profiláticos relacionados
DE69919349D1 (de) Piperidinyl- und n-amidinopiperidinyl-derivate
DE60116106D1 (de) Benzofuran derivate und ihre verwendung als antibakterielle wirkstoffe

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1282604

Country of ref document: EP

REN Ceased due to non-payment of the annual fee